POLISCOPE
Back to feed
HR6251FEDERALin_committee
High Impact

The HERO Act: Opioid Overdose Prevention in Schools

Original title: HERO Act

April 16, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Referred to the Subcommittee on Health.Nov 10, 2023
Lead sponsor

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

If passed, this bill would authorize $1 billion in federal funding through 2028 for private and public schools to stock overdose reversal medication and mandate that schools report all instances of drug distribution to federal tracking systems.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Local Educational Agencies

These agencies are eligible to apply for grants and are subject to new reporting requirements for drug distribution.

Private Schools

Private schools are eligible for grants and must comply with reporting requirements if they receive federal funds.

Department of Health and Human Services

The agency is tasked with administering the grant program and reporting to Congress.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

The HERO Act proposes a $1 billion federal grant program to help schools purchase opioid overdose reversal drugs and implement emergency response training. It also requires schools receiving federal funds to report any distribution of these drugs to national emergency and overdose tracking databases.

Key Facts

  • Authorizes $1 billion in federal appropriations for fiscal years 2024 through 2028 for school-based opioid overdose reversal programs.
  • Requires the Secretary of Health and Human Services to establish a competitive grant program for schools within 90 days of enactment.
  • Mandates that schools receiving federal funds report any distribution of opioid overdose reversal drugs to NEMSIS and ODMAP databases.
  • Grants are available to private elementary/secondary schools, local educational agencies, and charter schools.
  • Grant recipients must develop comprehensive emergency response plans in consultation with local health departments.
  • Grant recipients must implement educational programming on CPR, drug-use prevention, and overdose response.
  • Priority for grants is given to entities in cities or counties with high rates of opioid overdoses.
  • Grant periods are limited to 1 year.
  • Grant recipients must submit a report to the Secretary one year after the grant period ends detailing drug usage and emergency plans.
  • The Secretary must submit an annual report to Congress starting 2 years after enactment summarizing school reports.

Frequently Asked Questions

Which schools are eligible for these grants?
Eligible entities include private elementary and secondary schools, local educational agencies, and charter schools.
What must schools do if they distribute an overdose reversal drug?
Schools receiving federal funds must report the distribution to the National Emergency Medical Services Information System () and the Overdose Detection Mapping Application Program ().
What is the total funding authorized by this bill?
The bill authorizes $1 billion to be spent between fiscal years 2024 and 2028.

Why It Matters

If passed, this bill would authorize $1 billion in federal funding through 2028 for private and public schools to stock overdose reversal medication and mandate that schools report all instances of drug distribution to federal tracking systems.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Lobbying Activity

1-800 Contacts, Inc.

$200,000

2020

CONSUMER ISSUES/SAFETY/PRODUCTSHEALTH ISSUES

Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act.

1-800 Contacts, Inc.

$350,000

2020

CONSUMER ISSUES/SAFETY/PRODUCTSHEALTH ISSUES

Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act

1-800 Contacts, Inc.

$230,000

2020

CONSUMER ISSUES/SAFETY/PRODUCTSHEALTH ISSUES

Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act

1-800 Contacts, Inc.

$190,000

2020

CONSUMER ISSUES/SAFETY/PRODUCTSHEALTH ISSUES

Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Mandatory Federal Reporting

The bill shifts from voluntary school health reporting to a mandatory federal reporting requirement for any distribution of overdose reversal drugs by schools receiving federal funds.

Connected Entities

personRaul RuizCo-sponsor of the bill.Map →
personBonnie Watson ColemanCo-sponsor of the bill.Map →
personAdam SchiffU.S. Representative who introduced the bill.Map →
organizationDepartment of Health and Human ServicesResponsible for administering the grant program.Map →
personDavid TroneCo-sponsor of the bill.Map →
personAnn McLane KusterCo-sponsor of the bill.Map →
personJill TokudaCo-sponsor of the bill.Map →
personLinda SánchezCo-sponsor of the bill.Map →
organizationDepartment of EducationConsulted for grant administration and reporting.Map →

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy30
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record